Fny Investment Advisers, LLC Infla Rx N.V. Transaction History

Fny Investment Advisers, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$0.78 - $1.9 $15,600 - $38,000	-20,000 Reduced 20.0%	80,000 $116,000
Q4 2021 Jan 10, 2022	SELL	$2.35 - $5.58 $512,300 - $1.22 Million	-218,000 Reduced 68.55%	100,000 $476,000
Q3 2021 Oct 13, 2021	SELL	$2.25 - $3.03 $56,250 - $75,750	-25,000 Reduced 7.29%	318,000 $823,000
Q2 2021 Jul 14, 2021	SELL	$2.72 - $4.04 $19,040 - $28,280	-7,000 Reduced 2.0%	343,000 $1.02 Million
Q3 2020 Oct 09, 2020	BUY	$3.7 - $5.47 $518,000 - $765,800	140,000 Added 66.67%	350,000 $1.49 Million
Q2 2020 Jul 10, 2020	SELL	$4.59 - $8.96 $734,400 - $1.43 Million	-160,000 Reduced 43.24%	210,000 $963,000
Q1 2020 Apr 09, 2020	SELL	$2.65 - $6.08 $344,500 - $790,400	-130,000 Reduced 26.0%	370,000 $1.41 Million
Q3 2019 Oct 25, 2019	BUY	$2.47 - $3.51 $543,400 - $772,200	220,000 Added 78.57%	500,000 $1.24 Million
Q2 2019 Jul 24, 2019	BUY	$3.06 - $51.61 $856,800 - $14.5 Million	280,000 New	280,000 $884,000

12.9M

19.3K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $99M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.